MiniMed Group, Inc. Common Stock (MMED) Stock
NYSE · MMED
20.15
Fundamentals
Market cap
$5.62B
Price / Earnings ratio
-17.3x
Price / Sales ratio
1.9x
Price / Book ratio
1.6x
Return on assets
-8.0%
Ex-Dividend date
N/A
Last payment date
N/A
Dividend amount
$0.00
Dividend yield
0.00%
Debt / Equity ratio
N/A
Recent news

The Motley Fool
Why MiniMed Stock Was Soaring This Week
NeutralMMEDSeptember 4, 2026
The Motley FoolNeutral
Why MiniMed Stock Was Soaring This Week
MMED

Stocktwits
Why Did PFE, MMED, DE Stocks Surge To 52-Week Highs Today?
NeutralMMEDSeptember 2, 2026
StocktwitsNeutral
Why Did PFE, MMED, DE Stocks Surge To 52-Week Highs Today?
MMED

Stocktwits
These 2 Stocks Hit New Milestones Today – What’s Driving Retail Enthusiasm?
NeutralMMEDSeptember 1, 2026
StocktwitsNeutral
These 2 Stocks Hit New Milestones Today – What’s Driving Retail Enthusiasm?
MMED

MarketBeat
MiniMed Group Q1 Earnings Call Highlights
NeutralMMEDSeptember 1, 2026
MarketBeatNeutral
MiniMed Group Q1 Earnings Call Highlights
MMED
Technicals
OscillatorsSell5 Indicators
Moving AveragesSell10 Indicators
Analyst Ratings
Strong Sell0
Sell0
Neutral0
Buy9
Strong Buy0
Financials
Performance
Revenue
Net income
Net margin %
2025
2026
4B2B1B0
Debt & Balance Sheet
Total assets
Total liabilities
2025
2026
6B4B2B0
Revenue to Profit
2026$3.1B
Revenue$0.0
Cost of revenue$0.0
Gross profit$0.0
Operating expenses$-333.0M
Net incomeEarnings
No data available
% positive news of 10 articles
published over the past 14 days
Latest news

The Motley Fool
Why MiniMed Stock Was Soaring This Week
NeutralMMEDSeptember 4, 2026
The Motley FoolNeutral
Why MiniMed Stock Was Soaring This Week
MMED

Stocktwits
Why Did PFE, MMED, DE Stocks Surge To 52-Week Highs Today?
NeutralMMEDSeptember 2, 2026
StocktwitsNeutral
Why Did PFE, MMED, DE Stocks Surge To 52-Week Highs Today?
MMED

Stocktwits
These 2 Stocks Hit New Milestones Today – What’s Driving Retail Enthusiasm?
NeutralMMEDSeptember 1, 2026
StocktwitsNeutral
These 2 Stocks Hit New Milestones Today – What’s Driving Retail Enthusiasm?
MMED

MarketBeat
MiniMed Group Q1 Earnings Call Highlights
NeutralMMEDSeptember 1, 2026
MarketBeatNeutral
MiniMed Group Q1 Earnings Call Highlights
MMED

Zacks Investment Research
MiniMed Ships MiniMed Flex With Abbott's Smallest Instinct Sensor
NeutralMMEDAugust 20, 2026
Zacks Investment ResearchNeutral
MiniMed Ships MiniMed Flex With Abbott's Smallest Instinct Sensor
MMED

Zacks Investment Research
MMED Gets Medicare Coverage for Flex and Broadens Diabetes Care Access
NeutralMMEDJuly 27, 2026
Zacks Investment ResearchNeutral
MMED Gets Medicare Coverage for Flex and Broadens Diabetes Care Access
MMED

Zacks Investment Research
MiniMed Launches Abbott's Instinct Sensors Across European Markets
NeutralMMEDJune 24, 2026
Zacks Investment ResearchNeutral
MiniMed Launches Abbott's Instinct Sensors Across European Markets
MMED

MarketBeat
MiniMed Group Q4 Earnings Call Highlights
NeutralMMEDJune 3, 2026
MarketBeatNeutral
MiniMed Group Q4 Earnings Call Highlights
MMED

Zacks Investment Research
MMED's Latest Study Supports the Strength of 780G SmartGuard Algorithm
NeutralMMEDMay 22, 2026
Zacks Investment ResearchNeutral
MMED's Latest Study Supports the Strength of 780G SmartGuard Algorithm
MMED

Bloomberg Technology
MiniMed Aims to Be 'Self-Driving Car' of Diabetes Care
NeutralMMEDMay 15, 2026
Bloomberg TechnologyNeutral
MiniMed Aims to Be 'Self-Driving Car' of Diabetes Care
MMED
About MiniMed Group, Inc. Common Stock
MiniMed Group, Inc. is a scaled global medical technology company that develops, manufactures, and markets a comprehensive suite of solutions for the management of diabetes. Since its founding more than 40 years ago, the company has pioneered groundbreaking innovations and served the needs of customers around the world in pursuit of its mission to make every day a better day for people with diabetes.
SectorHealthcare
IndustryHealth Information Services
Employees8,000
CEOMs. Que Thanh Dallara
IPO DateMar 5, 2026
HeadquartersNorthridge, CA
Key Executives
| Name | Title | Year Born |
|---|---|---|
| Ms. Que Thanh Dallara | CEO & Director | 1974 |
| Mr. Chad J. Spooner | Executive VP & CFO | 1972 |
| Mr. Ali Dianaty | Executive VP and Chief Product & Technology Officer | 1975 |
| Ms. Courtney Nelson Wills | SVP, General Counsel & Corporate Secretary | 1976 |
| Ms. Gillian Chandrasena | Senior VP & Chief Human Resources Officer | 1974 |
| Mr. Christopher E. Eso | President | — |
| Mr. John Gyurci | VP, Chief Accounting Officer & Controller | 1971 |
| Mr. Mike Bruggeman | SVP & Chief Information Officer | — |
| Mr. Ryan Weispfenning | Head of Investor Relations | — |
| Ms. Yael Glassman | SVP, Chief Strategy & Corporate Development Officer | — |
Fundamentals
Valuation
Market cap$5.62B
Price-to-sales ratio1.85
Price-to-book value1.59
Price-earnings ratio-17.30
Return on Equity-10.00%
Return on Sales-7.00%
Return on Assets-8.00%
PEG ratioN/A
Earnings Per Share
Earnings Per Share$-1.30
Income Statement
Average volume2,605,778
EBITDA$-49.00M
1 year high (52w)$24.43
1 year low (52w)$10.65
Dividend
Ex dividend dateN/A
Dividend amount$0.00
Dividend yield0.00%
Last payment dateN/A
Dividend yield (TTM)N/A
Next earnings reportN/A
Solvency
Debt-to-equity ratioN/A
Technicals
OscillatorsSell5 Indicators
Moving AveragesSell10 Indicators
What the experts say
9 Wall Street Analyst Ratings
BUY
100% Buy
0% Hold
0% Sell
Target price
$26.56
Est return
32.78%
Seasonality
Monthly price change (%)| Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026 | -19.3 | -14.8 | -0.6 | +24.6 | +18.8 | +6.1 | -10.9 |



